Archives

Lightbeam Health Expands Agreement with Cardinal Health to Advance Enhancing Oncology Model Initiatives

Lightbeam Health

Lightbeam Health Solutions, the leader in population health enablement solutions and services, announces an expanded collaboration to deliver more solutions via Cardinal Health Navista TS, a suite of technology solutions developed to help community oncologists improve outcomes and costs associated with patient treatment for value-based care models.

The Enhancing Oncology Model (EOM) replaced the Oncology Care Model (OCM) in July 2023. As such, participating oncology practices will be required to engage in two-sided risk, as well as prioritize electronic Patient-Reported Outcomes (ePROs), health-related social needs screenings (HRSNs) and health equity programs. Through this expanded agreement, Cardinal Health will bolster its EOM offering with Lightbeam’s population health analytics application, Lightbeam Clinical Services (LCS) and Deviceless Remote Patient Monitoring.

Also Read: Tempus Announces Companion Diagnostic Collaboration with TScan Therapeutics 

“Lightbeam is honored to be Cardinal Health’s trusted partner for population health enablement solutions and capabilities,” says Patrick Burton, SVP of Business Development at Lightbeam Health Solutions. “With its expanded implementation of Lightbeam solutions, Navista TS is the all-in-one technology solution for patient-centered oncology care. This partnership highlights Lightbeam’s and Cardinal Health’s joint goal of delivering innovative solutions to help healthcare organizations drive outcomes and succeed in value-based care.”

As a comprehensive technology suite for patient-centric oncology care, Cardinal Health Navista TS helps oncology practices improve care, reduce administrative burdens, and strengthen financial performance. Cardinal Health began its relationship with Lightbeam by leveraging its prescriptive artificial intelligence (AI) solution, which identifies the high-risk SDoH factors that contribute to poor patient outcomes and increased ED utilization. Recent research published by ASCO’s Journal of Clinical Oncology found that the tool reduced monthly ED visits at a Texas cancer center by 18%.

“By expanding our relationship with Lightbeam Health, we can better support community oncologists who are looking to efficiently manage their population of patients,” says Amy Valley, PharmD, Vice President of Clinical Strategy and Technology Solutions at Cardinal Health. “The measurable success we have seen with community oncology practices that have adopted Lightbeam Health’s other value-based care tools, has been very promising, and we look forward to how this expansion will better support oncology patients in every phase of their care journeys.”

SOURCE: Businesswire